Suveda Inc.d/b/a Kerala Ayurveda Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Suveda Inc.d/b/a Kerala Ayurveda Pharmaceutical Import Records from India — 2 Products, $17.4K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Suveda Inc.d/b/a Kerala Ayurveda — Pharmaceutical Importer Profile (2026) | 2 Products, $17.4K Trade | TransData Nexus

Suveda Inc.d/b/a Kerala Ayurveda

Pharmaceutical Importer · United States · Ayurvedic & Herbal Products Focus · $17.4K Total Trade · DGFT Verified

Suveda Inc.d/b/a Kerala Ayurveda is a pharmaceutical importer based in United States with a total trade value of $17.4K across 2 products in 1 therapeutic categories. Based on 11 verified import shipments from Indian Customs (DGFT) records, Suveda Inc.d/b/a Kerala Ayurveda is the #1 buyer in 1 product including Adaptogen. Suveda Inc.d/b/a Kerala Ayurveda sources from 1 verified Indian supplier, with Kerala Ayurveda Limited accounting for 100.0% of imports.

Suveda Inc.d/b/a Kerala Ayurveda — Import Portfolio & Supplier Network

Suveda Inc.d/b/a Kerala Ayurveda import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Suveda Inc.d/b/a Kerala Ayurveda?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Kerala Ayurveda Limited	$1.0M	281	100.0%

Suveda Inc.d/b/a Kerala Ayurveda sources from 1 verified Indian supplier across 206 distinct formulations. The sourcing is highly concentrated — Kerala Ayurveda Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Ayurvedic products-gandha thailam	$117.1K	6
Ayurvedic products-mahathikthakam	$103.0K	4
Ayurvedic products-guluchyadi kwath	$102.3K	4
Ayurvedic products-dasamoolakaduthrayam	$101.9K	4
Ayurvedic products-kumkumadi oil 30 ML	$101.1K	3
Ayurvedic products-ksheerabala 101	$69.9K	3
Ayurvedic products-dhanwantharam	$62.1K	8
Ayurvedic products-dhanwantharam	$43.4K	4
Ayurvedic products-promactil capsule	$41.6K	4
Ayurvedic products-rg forte tablet 60	$41.1K	3
Ayurvedic products-nisakathakadi kwath	$37.5K	4
Ayurvedic products-mahamasha thailam	$35.0K	4
Ayurvedic products-glymin tablet 90	$31.0K	4
Ayurvedic products-mahanarayana	$26.9K	4
Ayurvedic products-punarnavasavam 450 ML	$14.4K	3

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Asava	Ayurvedic & Herbal Products	$14.5K	4	3.2%	5
2	Adaptogen	Ayurvedic & Herbal Products	$2.9K	7	46.6%	1

Suveda Inc.d/b/a Kerala Ayurveda imports 2 pharmaceutical products across 1 categories into United States totaling $17.4K. The company is the #1 buyer for 1 product: Adaptogen.

Suveda Inc.d/b/a Kerala Ayurveda — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Suveda Inc., operating as Kerala Ayurveda, is a U.S.-based pharmaceutical importer specializing in Ayurvedic and herbal products. Headquartered at 691 S Milpitas Blvd, Milpitas, California, the company imports finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, from India. Suveda Inc. is a wholly owned subsidiary of Kerala Ayurveda Limited, an India-based company engaged in the manufacture of Ayurvedic products, research, academies, clinics, hospitals, wellness resorts, and the cultivation of medicinal herbs.

In the United States pharmaceutical distribution landscape, Suveda Inc. serves as a niche importer, focusing on Ayurvedic and herbal formulations. By leveraging its parent company's extensive network and expertise in Ayurvedic medicine, Suveda Inc. plays a pivotal role in introducing traditional Indian remedies to the U.S. market, catering to consumers seeking alternative and complementary health solutions.

2Distribution Network

Suveda Inc. operates its distribution network primarily from its headquarters in Milpitas, California. While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic position in California facilitates efficient distribution across the United States. California's robust infrastructure, including major ports and transportation networks, supports Suveda Inc.'s ability to manage imports and deliveries effectively. The company's focus on Ayurvedic and herbal products suggests a targeted distribution approach, likely emphasizing regions with higher demand for alternative health products.

3Industry Role

Suveda Inc., operating as Kerala Ayurveda, functions as a specialized pharmaceutical importer within the U.S. market. By focusing exclusively on Ayurvedic and herbal formulations imported from India, the company serves a niche segment of consumers interested in traditional and alternative health remedies. This strategic positioning allows Suveda Inc. to cater to a growing demand for natural and holistic health solutions, differentiating itself from mainstream pharmaceutical distributors.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Suveda Inc.d/b/a Kerala Ayurveda

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Suveda Inc. demonstrates a high degree of supplier concentration, sourcing all its imported products from a single supplier, Kerala Ayurveda Limited. This single-source dependency indicates a strategic choice to maintain consistency and quality control over the imported formulations. The substantial volume of imports—totaling $17,000 across 11 shipments—reflects a stable and ongoing relationship between Suveda Inc. and Kerala Ayurveda Limited. However, this concentration also exposes Suveda Inc. to potential risks associated with supply chain disruptions, such as production delays or regulatory changes affecting the sole supplier.

2Supply Chain Resilience

The resilience of Suveda Inc.'s supply chain is closely tied to its exclusive relationship with Kerala Ayurveda Limited. While this partnership ensures product consistency and quality, it also means that any disruptions within Kerala Ayurveda Limited—such as production issues, regulatory challenges, or logistical problems—could directly impact Suveda Inc.'s ability to meet U.S. market demands. The lack of publicly available information regarding backup suppliers or alternative sourcing strategies suggests a potential vulnerability in the supply chain. To enhance resilience, Suveda Inc. may consider diversifying its supplier base or establishing contingency plans to mitigate risks associated with sole-source dependency.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and marketing of pharmaceutical products, including Ayurvedic and herbal formulations. The FDA enforces regulations to ensure that imported drugs meet safety, efficacy, and quality standards. Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act, which outlines requirements for drug approval, labeling, and manufacturing practices. For Indian generics, the FDA's Abbreviated New Drug Application (ANDA) pathway allows for the approval of generic drugs based on bioequivalence to a reference listed drug, facilitating market entry for generic formulations.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in the U.S. are stringent. Importers must ensure that their products comply with FDA regulations, which may include obtaining an import license and providing evidence of Good Manufacturing Practice (GMP) compliance. The FDA recognizes GMP certifications from reputable international bodies, such as the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S), provided they meet FDA standards. Importers must also obtain wholesale distribution authorization, which involves registration with state authorities and adherence to specific state regulations governing the distribution of pharmaceutical products.

Suveda Inc.d/b/a Kerala Ayurveda — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Suveda Inc.'s focus on Ayurvedic and herbal products aligns with a growing consumer interest in natural and alternative health solutions in the United States. The company's import strategy emphasizes products that cater to specific therapeutic areas, such as adaptogens and asavas, which are traditional Ayurvedic formulations used to balance bodily functions and promote overall health. Market demand for these products is driven by consumers seeking holistic approaches to health and wellness, as well as a desire for natural remedies with fewer side effects compared to conventional pharmaceuticals.

2Sourcing Profile

Suveda Inc.'s sourcing strategy is centered on importing finished pharmaceutical formulations from India, specifically from Kerala Ayurveda Limited. This approach ensures product authenticity and quality, as Kerala Ayurveda Limited is a well-established manufacturer with expertise in Ayurvedic medicine. The focus on finished formulations allows Suveda Inc. to offer ready-to-market products, streamlining the supply chain and reducing time to market. India's rich heritage in Ayurvedic medicine and its established manufacturing capabilities make it a strategic sourcing partner for Suveda Inc.

3Market Positioning

Seller's Guide — How to Become a Supplier to Suveda Inc.d/b/a Kerala Ayurveda

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Suveda Inc., especially if they can offer unique Ayurvedic formulations that complement the existing product portfolio. However, the exclusivity of Suveda Inc.'s relationship with Kerala Ayurveda Limited may limit opportunities for other exporters unless they can provide distinctive products or formulations. Suppliers should also be prepared to meet the stringent regulatory requirements of the U.S. market, including FDA compliance and GMP certifications.

2Requirements & Qualifications

Indian exporters seeking to supply Suveda Inc. and enter the U.S. market must obtain FDA approval for their products, which involves demonstrating safety, efficacy, and quality. Products must comply with FDA regulations, including labeling requirements and GMP standards. Additionally, exporters should ensure that their products meet the specific needs and preferences of the U.S. consumer market, which may involve adapting formulations or packaging to align with local expectations.

3How to Approach

Frequently Asked Questions — Suveda Inc.d/b/a Kerala Ayurveda

What products does Suveda Inc.d/b/a Kerala Ayurveda import from India?

Suveda Inc.d/b/a Kerala Ayurveda imports 2 pharmaceutical products across 1 categories. Top imports: Asava ($14.5K), Adaptogen ($2.9K).

Who supplies pharmaceuticals to Suveda Inc.d/b/a Kerala Ayurveda from India?

Suveda Inc.d/b/a Kerala Ayurveda sources from 1 verified Indian suppliers. The primary supplier is Kerala Ayurveda Limited (100.0% of imports, $1.0M).

What is Suveda Inc.d/b/a Kerala Ayurveda's total pharmaceutical import value?

Suveda Inc.d/b/a Kerala Ayurveda's total pharmaceutical import value from India is $17.4K, based on 11 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Suveda Inc.d/b/a Kerala Ayurveda focus on?

Suveda Inc.d/b/a Kerala Ayurveda imports across 1 categories. The largest: Ayurvedic & Herbal Products (100.0%).

Get Full Suveda Inc.d/b/a Kerala Ayurveda Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.